Insights

Expanding Footprint Eurofins CDMO is investing heavily in expanding its facilities, exemplified by the recent $147 million investment in a new 300,000-square-foot biopharmaceutical testing center in Pennsylvania. This growth indicates a strong capacity to support large-scale production and a potential need for supply chain and logistics partners to manage increased testing and manufacturing activities.

Strategic Acquisitions The company's recent divestment of its electrical and electronics testing business and focus on core biopharmaceutical services present opportunities to offer specialized solutions such as regulatory compliance consulting, advanced analytical testing, and process automation to streamline development workflows.

Technology and Innovation Eurofins' emphasis on breakthrough technologies like capillary electrophoresis-mass spectrometry and development of complex formulations suggests a need for advanced laboratory instrumentation, digital data management, and collaborative software solutions to enhance research precision and operational efficiency.

Global Regulatory Presence Operating under strict accreditation from agencies like FDA, EMA, and Health Canada showcases a commitment to regulatory excellence, providing an opportunity to offer compliance management systems, training programs, and regulatory intelligence services to facilitate smooth client approvals across multiple regions.

Industry Collaboration Eurofins' strategic partnerships with organizations like TRI Princeton and CMP Scientific highlight a focus on accelerating drug development and characterization. These collaborations indicate potential sales avenues in clinical testing services, advanced characterization tools, and integrated project management platforms to support joint innovation initiatives.

Amatsigroup Tech Stack

Amatsigroup uses 8 technology products and services including Methode, NetSuite CRM, Windows Deployment Services, and more. Explore Amatsigroup's tech stack below.

  • Methode
    Content Management System
  • NetSuite CRM
    Customer Relationship Management
  • Windows Deployment Services
    Deployment
  • Deltek
    Enterprise Resource Planning
  • Microsoft Dynamics AX
    Enterprise Resource Planning
  • GLPI
    Help Desk Management
  • Site24x7
    Real User Monitoring
  • Skype
    Unified Communications

Media & News

Amatsigroup's Email Address Formats

Amatsigroup uses at least 2 format(s):
Amatsigroup Email FormatsExamplePercentage
First.Last@amatsigroup.comJohn.Doe@amatsigroup.com
53%
F.Last@amatsigroup.comJ.Doe@amatsigroup.com
31%
First@amatsigroup.comJohn@amatsigroup.com
10%
FirstLast@amatsigroup.comJohnDoe@amatsigroup.com
4%
Last@amatsigroup.comDoe@amatsigroup.com
2%
FirstLast@eurofins.comJohnDoe@eurofins.com
93%
FirLast@eurofins.comJohDoe@eurofins.com
3%
FirstMiddleLast@eurofins.comJohnMichaelDoe@eurofins.com
2%
FirstLas@eurofins.comJohnDoe@eurofins.com
2%

Frequently Asked Questions

Where is Amatsigroup's headquarters located?

Minus sign iconPlus sign icon
Amatsigroup's main headquarters is located at 2 Bis Avenue de Gascogne Fontenilles, Occitanie 31470 France. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Amatsigroup's phone number?

Minus sign iconPlus sign icon
You can contact Amatsigroup's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amatsigroup's official website and social media links?

Minus sign iconPlus sign icon
Amatsigroup's official website is eurofins.com and has social profiles on LinkedIn.

What is Amatsigroup's SIC code NAICS code?

Minus sign iconPlus sign icon
Amatsigroup's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Amatsigroup have currently?

Minus sign iconPlus sign icon
As of April 2026, Amatsigroup has approximately 392 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Director Drug Substance & Drug Product Manufacturing: D. A.Managing Director: Y. G.Pharmaceutical Development Manager (drug Product Department): A. F.. Explore Amatsigroup's employee directory with LeadIQ.

What industry does Amatsigroup belong to?

Minus sign iconPlus sign icon
Amatsigroup operates in the Pharmaceutical Manufacturing industry.

What technology does Amatsigroup use?

Minus sign iconPlus sign icon
Amatsigroup's tech stack includes MethodeNetSuite CRMWindows Deployment ServicesDeltekMicrosoft Dynamics AXGLPISite24x7Skype.

What is Amatsigroup's email format?

Minus sign iconPlus sign icon
Amatsigroup's email format typically follows the pattern of First.Last@amatsigroup.com. Find more Amatsigroup email formats with LeadIQ.

When was Amatsigroup founded?

Minus sign iconPlus sign icon
Amatsigroup was founded in 2010.

Amatsigroup

Pharmaceutical ManufacturingOccitanie, France201-500 Employees

Eurofins CDMO is a leading global Contract Development and Manufacturing Organization (CDMO) that provides clients with APIs / Drug Substance and Drug Product development for biologicals and small molecules. Science is our fondation and allows us to support small and major biopharmaceutical companies. Our sustainable and flexible methods help them achieve their pre-clinical and clinical milestones on time.

We are experts in breakthrough technologies for API development, highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, pediatric dosage forms, etc.)

Involved in the earliest steps, our highly-qualified project management team will propose a complete drug development strategy in compliance with regulations. Frequent communication through one single point of contact, our team's flexibility, troubleshooting mindset, customized solutions will help speed up the drug development process. Operating under strict quality procedures, Eurofins CDMO is accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and Health Canada.

Our goal is to build a sustainable partnership with our customers to support their drug development pathway.

Our service offerings include:
- Drug Substance/API development
- Solid State Research & Development
- Pre-Formulation, Formulation Development
- Analytical Development
- GMP Manufacturing
- Clinical packaging and logistics
- Project management
- CMC RA

Choose Eurofins CDMO to help you:
- Move rapidly through the drug development value chain (API/DS and DP)
- Perform complex formulation screening and development
- Accelerate process development and scale-up under GMP compliance
- Achieve clinical & small commercial manufacturing batches (Sterile and Non Sterile)
- Provide clinical trial material including packaging and logistics
- Ensure regulatory compliance throughout each stage of the development cycle with full CMC-RA support

Section iconCompany Overview

Headquarters
2 Bis Avenue de Gascogne Fontenilles, Occitanie 31470 France
Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2010
Employees
201-500

Section iconFunding & Financials

  • $1M$10M

    Amatsigroup's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Amatsigroup's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.